Clinical trial · Interventional
Magnetic Anchoring Guided Endoscopic Submucosal Dissection for Early Gastric Caner
Prospective Clinical Trial of Magnetic Anchoring Guided Endoscopic Submucosal Dissection for Early Gastric Caner
NCT04327050CI-TRIAL-00044321MAGESDunknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study uses magnetic anchored guidance system to treat early gastric cancer by endoscopic mucosal dissection to test the advantages of magnetically anchored guidance system for surgical field exposure during endoscopic mucosal dissection.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Gastric Cancer | Malignant Gastric Neoplasm | CURATED_BROADER | 0.80 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Magnetic anchored guided endoscopic submucosal dissection | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Magnetic-ESD
- description
- Patients in MAG arm will be treated using magnetic anchored guided endoscopic submucosal dissection.
- interventionNames
- Procedure: Magnetic anchored guided endoscopic submucosal dissection
Primary outcomes (1)
- measure
- success rate
- timeFrame
- through study completion, an average of 1 year
- description
- The rate of the complete resection of gastric lesion by magnetic anchored guided endoscopic submucosal dissection
Secondary outcomes (1)
- measure
- complications
- timeFrame
- measured at the time of the end of each ESD; up to 1 hour
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 60 Years
Show eligibility criteria text
Inclusion Criteria: * Patients are diagnosed as of gastric cancer by a preliminary endoscopy or biopsy sampling Exclusion Criteria: * Patients with a cardiac pacemaker or severe cardiac and/or pulmonary diseases * Patients without informed consent * Patients with other malignant tumors
References
Publications (0)
Data not yet available
No reference posted for this study.